SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-17-254597
Filing Date
2017-08-10
Accepted
2017-08-10 16:59:51
Documents
58
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d377935d10q.htm 10-Q 652294
2 EX-10.1 d377935dex101.htm EX-10.1 114715
3 EX-10.2 d377935dex102.htm EX-10.2 42339
4 EX-31.1 d377935dex311.htm EX-31.1 6850
5 EX-31.2 d377935dex312.htm EX-31.2 6870
6 EX-32.1 d377935dex321.htm EX-32.1 4396
13 GRAPHIC g377935g0802205819750.jpg GRAPHIC 1203
  Complete submission text file 0001193125-17-254597.txt   3291280

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE DOCUMENT sndx-20170630.xml EX-101.INS 464648
8 XBRL TAXONOMY EXTENSION SCHEMA sndx-20170630.xsd EX-101.SCH 40121
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE sndx-20170630_cal.xml EX-101.CAL 50837
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE sndx-20170630_def.xml EX-101.DEF 131387
11 XBRL TAXONOMY EXTENSION LABEL LINKBASE sndx-20170630_lab.xml EX-101.LAB 322902
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sndx-20170630_pre.xml EX-101.PRE 225328
Mailing Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451
Business Address 400 TOTTEN POND ROAD SUITE 110 WALTHAM MA 02451 781-419-1400
Syndax Pharmaceuticals Inc (Filer) CIK: 0001395937 (see all company filings)

IRS No.: 320162505 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37708 | Film No.: 171022134
SIC: 2834 Pharmaceutical Preparations